1st Quarter - Report
AMGEN, INC. for AMGEN INC
Firm
Client
Income
—
Expenses
$2,520,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Intellectual property and process patent issues S. 1145 and H.R.. 1908 Patent Reform Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BEIER | — |
| CHAKA BURGESS | — |
| L NICOLE CURRIE | — |
| RODGER CURRIE | — |
| MARA GUARDUCCI | — |
| JESSE KERNS | — |
| REBECCA MANDELL | — |
| HOWARD MOON | — |
| WILLIAM O'BRIEN | — |
| SCOTT OLSEN | — |
| HELEN RHEE | — |
Health Issues HCR
FDA Drug Safety Oversight Follow-On-Biologics H.R. 1038, Access to Life-saving Medicines Act H.R. 1956, Patient Protection and Innovative Biologics Medicines Act of 2007 HR. 5629, Pathway for Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BEIER | — |
| CHAKA BURGESS | — |
| L NICOLE CURRIE | — |
| RODGER CURRIE | — |
| MARA GUARDUCCI | — |
| JESSE KERNS | — |
| REBECCA MANDELL | — |
| HOWARD MOON | — |
| WILLIAM O'BRIEN | — |
| SCOTT OLSEN | — |
| GREGORY PORTNER | — |
| HELEN RHEE | — |
Medicare/Medicaid MMM
Medicare Coverage and Reimbursement Issues Implementation of the Medicaid Drug Rebate Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BEIER | — |
| CHAKA BURGESS | — |
| L NICOLE CURRIE | — |
| RODGER CURRIE | — |
| MARA GUARDUCCI | — |
| JESSE KERNS | — |
| CHRISTOPHER MANCILL | — |
| REBECCA MANDELL | — |
| HOWARD MOON | — |
| WILLIAM O'BRIEN | — |
| SCOTT OLSEN | — |
| GREGORY PORTNER | — |
| HELEN RHEE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.